A Study to Evaluate the Efficacy of MEDI7510 in Older Adults
Public ClinicalTrials.gov record NCT02508194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized, Double-blind Study to Evaluate the Efficacy of MEDI7510 for the Prevention of Acute Respiratory Syncytial Virus-associated Respiratory Illness in Older Adults
Study identification
- NCT ID
- NCT02508194
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MedImmune LLC
- Industry
- Enrollment
- 1,900 participants
Conditions and interventions
Conditions
Interventions
- IIV Biological
- MEDI7510 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 60 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2015
- Primary completion
- Sep 8, 2016
- Completion
- Nov 6, 2016
- Last update posted
- Dec 25, 2017
2015 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Sacramento | California | 95864 | — |
| Research Site | San Francisco | California | 94108 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Littleton | Colorado | 80127 | — |
| Research Site | Lady Lake | Florida | 32159 | — |
| Research Site | Miami | Florida | 33143 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Champaign | Illinois | 61820 | — |
| Research Site | Chicago | Illinois | 60654 | — |
| Research Site | Council Bluffs | Iowa | 51503 | — |
| Research Site | Augusta | Kansas | 67010 | — |
| Research Site | Wichita | Kansas | 67205 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Cincinnati | Missouri | 45249 | — |
| Research Site | Kansas City | Missouri | 64114 | — |
| Research Site | Bellevue | Nebraska | 68005 | — |
| Research Site | Norfolk | Nebraska | 68701 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Rochester | New York | 14621 | — |
| Research Site | Charlotte | North Carolina | 28209 | — |
| Research Site | Hickory | North Carolina | 28602 | — |
| Research Site | Raleigh | North Carolina | 27609 | — |
| Research Site | Rocky Mount | North Carolina | 27804 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Akron | Ohio | 44311 | — |
| Research Site | Dakota Dunes | South Dakota | 57049 | — |
| Research Site | Knoxville | Tennessee | 37912 | — |
| Research Site | Nashville | Tennessee | 37212 | — |
| Research Site | Murray | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02508194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 25, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02508194 live on ClinicalTrials.gov.